COLLIN WURST: Open Payments
NPI 1144856634 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 38 payments from 18 companies in 2025. Trend: 2023 $1,008 · 2024 $1,180 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $227 |
| Novo Nordisk Inc | 6 | $130 |
| Smith+Nephew, Inc. | 2 | $60 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $51 |
| Lilly USA, LLC | 2 | $34 |
| Exact Sciences Corporation | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Endo USA, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: QULIPTA, Ozempic, PICO, UBRELVY, JOURNAVX, Wegovy, MOUNJARO, Cologuard Collection Kit.
Industry payments across PA — which companies pay providers there.
